REVELATION BIOSCIENCES, INC.

Revelation Biosciences, Inc., filing under the ticker PAIC on the Nasdaq, submitted a Form 10-Q with the SEC on August 23, 2021, under accession number 0001213900-21-044217. PAIC is the vehicle of Panacea Acquisition Corp. II, a blank-check company sponsored by Panacea Capital Group and focused on the healthcare and life sciences sector. The SPAC completed its initial public offering in 2021 and operated in the biopharmaceutical and diagnostics space, reflecting the sponsor's stated focus on health and wellness innovation. The August 2021 quarterly filing captures a snapshot of the company's financial position during its active SPAC lifecycle. For complete filing history, ownership data, and deal timelines on PAIC and hundreds of other SPACs, sign up for full access at SpacDesk.